Parallel drugs trade is legitimate, safe and delivers savings to taxpayer

I REFER to your report headlined ‘Counterfeit drugs will kill, expert warns’ (Irish Examiner, October 12).

Parallel drugs trade is legitimate, safe and delivers savings to taxpayer
Fri, 21 Oct, 2005 - 01:00

Counterfeiting medicines is a crime. It is a dangerous activity that can lead to the patient's condition worsening rather than improving.

As such, Pfizer is perfectly right to drive a campaign against counterfeits.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €10/month. Ts&Cs apply.

More in this section

Letters to the Editor: Let’s reopen access for the public to our heritage sites Letters to the Editor: Let’s reopen access for the public to our heritage sites
Popcorn with the headphone, a headphone plugged into the popcorn box, concept of entertainment Letters to the Editor: Cinemas should have audio description for visually-impaired people
Disability stock Letters to the Editor: My disability doesn’t stop me working, the State does
CourtsYour ViewPlace: UKPerson: Graham SatchwellPerson: Patrick WaddingOrganisation: Irish ExaminerOrganisation: PfizerOrganisation: ViagraOrganisation: LipitorOrganisation: European associationOrganisation: Irish GovernmentOrganisation: PCO Manufacturing LtdOrganisation: Western Industrial Estate Dublin 12
<p>Health minister Jennifer Carroll MacNeill said it was time to 'further integrate paediatric care formally into the HSE' ahead of the move to the new National Children’s Hospital, having spent several months reviewing governance structures in the health service generally. Picture: Colin Keegan/Collins</p>

Irish Examiner view: Is CHI merger more than just a U-turn?

READ NOW

Revoiced

Newsletter

Sign up to the best reads of the week from irishexaminer.com selected just for you.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited